ADUS
Price
$120.81Alerts
Change
-$0.75 (-0.62%)
Updated
Nov 18, 04:59 PM (EDT)
Capitalization
2.32B
103 days until earnings call
Intraday BUY SELL Signals
FMS
Price
$20.95Alerts
Change
-$0.74 (-3.41%)
Updated
Nov 18, 04:59 PM (EDT)
Capitalization
12.45B
97 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ADUS vs FMS

ADUS vs FMS Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ADUS vs. FMS commentary
Nov 19, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADUS is a Hold and FMS is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ADUS with price predictions
Nov 17, 2026

ADUS's RSI Indicator recovers from overbought zone

The 10-day RSI Oscillator for ADUS moved out of overbought territory on November 06, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 instances where the indicator moved out of the overbought zone. In 24 of the 30 cases the stock moved lower in the days that followed. This puts the odds of a move down at 80%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ADUS as a result. In 57 of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 66%.

The Moving Average Convergence Divergence Histogram (MACD) for ADUS turned negative on November 12, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 33 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 70%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ADUS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 62%.

ADUS broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

ADUS moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ADUS crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 16 of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 80%.

Following a +1.74% 3-day Advance, the price is estimated to grow further. Considering data from situations where ADUS advanced for three days, in 202 of 310 cases, the price rose further within the following month. The odds of a continued upward trend are 65%.

The Aroon Indicator entered an Uptrend today. In 141 of 218 cases where ADUS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 65%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. ADUS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 46 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is 57 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 72 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.022) is normal, around the industry mean (204.532). P/E Ratio (21.433) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (0.983) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.154) among similar stocks. P/S Ratio (1.483) is also within normal values, averaging (2.688).

The Tickeron SMR rating for this company is 72 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
a Summary for FMS with price predictions
Nov 17, 2026

FMS sees MACD Histogram just turned negative

FMS saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 12, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 45 instances where the indicator turned negative. In 31 of the 45 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 69%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 11, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FMS as a result. In 48 of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 61%.

FMS moved below its 50-day moving average on November 11, 2026 date and that indicates a change from an upward trend to a downward trend.

The 50-day moving average for FMS moved below the 200-day moving average on October 26, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FMS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The 10-day moving average for FMS crossed bullishly above the 50-day moving average on November 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 56%.

Following a +8.88% 3-day Advance, the price is estimated to grow further. Considering data from situations where FMS advanced for three days, in 193 of 318 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.

The Aroon Indicator entered an Uptrend today. In 148 of 266 cases where FMS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 56%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 6 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.992) is normal, around the industry mean (204.532). P/E Ratio (14.096) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (0.741) is also within normal values, averaging (2.498). Dividend Yield (0.149) settles around the average of (0.154) among similar stocks. P/S Ratio (0.574) is also within normal values, averaging (2.688).

The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating fairly steady price growth. FMS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 65 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 78 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FMS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

FUNDAMENTALS RATINGS
ADUS vs FMS: Fundamental Ratings
ADUS
FMS
OUTLOOK RATING
1..100
8854
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
6
Undervalued
PROFIT vs RISK RATING
1..100
46100
SMR RATING
1..100
7278
PRICE GROWTH RATING
1..100
4157
P/E GROWTH RATING
1..100
5765
SEASONALITY SCORE
1..100
1185

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FMS's Valuation (6) in the Medical Or Nursing Services industry is significantly better than the same rating for ADUS (72). This means that FMS’s stock grew significantly faster than ADUS’s over the last 12 months.

ADUS's Profit vs Risk Rating (46) in the Medical Or Nursing Services industry is somewhat better than the same rating for FMS (100). This means that ADUS’s stock grew somewhat faster than FMS’s over the last 12 months.

ADUS's SMR Rating (72) in the Medical Or Nursing Services industry is in the same range as FMS (78). This means that ADUS’s stock grew similarly to FMS’s over the last 12 months.

ADUS's Price Growth Rating (41) in the Medical Or Nursing Services industry is in the same range as FMS (57). This means that ADUS’s stock grew similarly to FMS’s over the last 12 months.

ADUS's P/E Growth Rating (57) in the Medical Or Nursing Services industry is in the same range as FMS (65). This means that ADUS’s stock grew similarly to FMS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ADUSFMS
RSI
ODDS (%)
Bearish Trend 2 days ago
80%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
53%
Momentum
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
61%
MACD
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
62%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
64%
Bearish Trend 2 days ago
62%
Advances
ODDS (%)
Bullish Trend 15 days ago
65%
Bullish Trend 14 days ago
61%
Declines
ODDS (%)
Bearish Trend 6 days ago
62%
Bearish Trend 2 days ago
64%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
62%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 2 days ago
56%
COMPARISON
Comparison
Nov 19, 2026
Stock price -- (ADUS: $121.56 vs. FMS: $21.69)
Brand notoriety: ADUS and FMS are both not notable
Both companies represent the Hospital/Nursing Management industry
Current volume relative to the 65-day Moving Average: ADUS: 44% vs. FMS: 67%
Market capitalization -- ADUS: $2.32B vs. FMS: $12.45B
ADUS [@Hospital/Nursing Management] is valued at $2.32B. FMS’s [@Hospital/Nursing Management] market capitalization is $12.45B. The market cap for tickers in the [@Hospital/Nursing Management] industry ranges from $20.9K to $107.17B. The average market capitalization across the [@Hospital/Nursing Management] industry is $5.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADUS’s FA Score shows that 0 FA rating(s) are green while FMS’s FA Score has 1 green FA rating(s).

  • ADUS’s FA Score: 0 green, 5 red.
  • FMS’s FA Score: 1 green, 4 red.
According to our system of comparison, ADUS is a better buy in the long-term than FMS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADUS’s TA Score shows that 5 TA indicator(s) are bullish while FMS’s TA Score has 4 bullish TA indicator(s).

  • ADUS’s TA Score: 5 bullish, 5 bearish.
  • FMS’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ADUS is a better buy in the short-term than FMS.

Price Growth

ADUS (@Hospital/Nursing Management) experienced а -3.75% price change this week, while FMS (@Hospital/Nursing Management) price change was -4.62% for the same time period.

The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -10.44%. For the same industry, the average monthly price growth was -7.09%, and the average quarterly price growth was +3.25%.

Reported Earning Dates

ADUS is expected to report earnings on Mar 01, 2027.

FMS is expected to report earnings on Feb 23, 2027.

Industries' Descriptions

@Hospital/Nursing Management (-10.44% weekly)

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

ADUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADUS has been loosely correlated with PNTG. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ADUS jumps, then PNTG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADUS
1D Price
Change %
ADUS100%
-2.45%
PNTG - ADUS
41%
Loosely correlated
-1.43%
HCSG - ADUS
38%
Loosely correlated
-0.68%
NHC - ADUS
36%
Loosely correlated
-0.69%
ENSG - ADUS
34%
Loosely correlated
-1.17%
CON - ADUS
32%
Poorly correlated
-2.44%
More

FMS and

Correlation & Price change

A.I.dvisor indicates that over the last year, FMS has been loosely correlated with DVA. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if FMS jumps, then DVA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FMS
1D Price
Change %
FMS100%
-0.78%
DVA - FMS
38%
Loosely correlated
-0.70%
ADUS - FMS
32%
Poorly correlated
-2.45%
MD - FMS
32%
Poorly correlated
-2.38%
CON - FMS
31%
Poorly correlated
-2.44%
EHC - FMS
27%
Poorly correlated
-2.98%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
POLY.X0.0749940.074248
+9946.32%
Polymath cryptocurrency
IMX.X0.0998050.003766
+3.92%
Immutable cryptocurrency
SPELL.X0.0000650.000001
+1.52%
Spell Token cryptocurrency
BUSD.X0.999447-0.000620
-0.06%
BUSD cryptocurrency
REN.X0.002002-0.000056
-2.72%
Ren cryptocurrency